Related references
Note: Only part of the references are listed.Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors
S. R. Kumar et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
PD-1 expression by canine T cells and functional effects of PD-1 blockade
J. Coy et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp paratuberculosis-Specific T-Cell Responses
Tomohiro Okagawa et al.
INFECTION AND IMMUNITY (2016)
Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle
Tomohiro Okagawa et al.
INFECTION AND IMMUNITY (2016)
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Naoya Maekawa et al.
PLOS ONE (2016)
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma
Sarah M. Rue et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2015)
Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document
S. M. Nguyen et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2015)
Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes
Ryoyo Ikebuchi et al.
IMMUNOLOGY (2014)
Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
Josef Singer et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Comparative functional characterization of canine IgG subclasses
Lisa M. Bergeron et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2014)
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
Mario Sznol et al.
CLINICAL CANCER RESEARCH (2013)
Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
Mizuki Nishino et al.
CLINICAL CANCER RESEARCH (2013)
Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro
Ryoyo Ikebuchi et al.
VETERINARY RESEARCH (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade
Ryoyo Ikebuchi et al.
VETERINARY RESEARCH (2011)
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Marguerite Ghiotto et al.
INTERNATIONAL IMMUNOLOGY (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Methods and mortality results of a health survey of purebred dogs in the UK
V. J. Adams et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
Raymond M. Wong et al.
INTERNATIONAL IMMUNOLOGY (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Canine oral melanoma
Philip J. Bergman
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
C Blank et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A comparative review of melanocytic neoplasms
SH Smith et al.
VETERINARY PATHOLOGY (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cloning and characterization of cDNAs encoding four different canine immunoglobulin γ chains
L Tang et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Share Paper
